These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 16839816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Biopharmaceutical drug targeting to the brain.
    Pardridge WM.
    J Drug Target; 2010 Apr; 18(3):157-67. PubMed ID: 20064077
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neurotrophins, neuroprotection and the blood-brain barrier.
    Pardridge WM.
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1753-7. PubMed ID: 12528312
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug targeting to the brain.
    Pardridge WM.
    Pharm Res; 2007 Sep; 24(9):1733-44. PubMed ID: 17554607
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.
    Boado RJ, Zhang Y, Zhang Y, Xia CF, Wang Y, Pardridge WM.
    Biotechnol Bioeng; 2008 Feb 01; 99(2):475-84. PubMed ID: 17680664
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blood-brain barrier delivery.
    Pardridge WM.
    Drug Discov Today; 2007 Jan 01; 12(1-2):54-61. PubMed ID: 17198973
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK, Boado RJ, Pardridge WM.
    Mol Pharm; 2009 Jan 01; 6(5):1536-43. PubMed ID: 19624167
    [Abstract] [Full Text] [Related]

  • 18. Drug and gene targeting to the brain with molecular Trojan horses.
    Pardridge WM.
    Nat Rev Drug Discov; 2002 Feb 01; 1(2):131-9. PubMed ID: 12120094
    [Abstract] [Full Text] [Related]

  • 19. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse.
    Lee HJ, Engelhardt B, Lesley J, Bickel U, Pardridge WM.
    J Pharmacol Exp Ther; 2000 Mar 01; 292(3):1048-52. PubMed ID: 10688622
    [Abstract] [Full Text] [Related]

  • 20. Targeted delivery of protein and gene medicines through the blood-brain barrier.
    Pardridge WM.
    Clin Pharmacol Ther; 2015 Apr 01; 97(4):347-61. PubMed ID: 25669455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.